Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulinreceptors

The insulin-like growth factor-II receptor (IGF-IIR) is frequently mutated or deleted in some malignant human tumors, suggesting that the IGF-IIR is a tumor suppressor. However, the exact mechanism by which IGF-IIR suppresses growth in tumors has not been definitively established. We demonstrate tha t IGF-IIR-deficient murine L cells (D9) have higher growth rates than IGF-I IR-positive L cells (Cc2) in response to IGF-II. IGF-II levels are higher i n growth-conditioned medium from D9 versus Cc2 cells. Receptor neutralizati on studies and measurements of insulin receptor substrate 1 phosphorylation confirm that the enhanced growth of D9 cells is due to increased stimulati on of the IGF-I and insulin receptors by IGF-II. In contrast, the levels of secreted latent and active transforming growth factor P (TGF-P) are simila r for both D9 and Cc2 cells, indicating that the slower growth of Cc2 cells is not due to activation of latent TGF-P by IGF-IIR and growth inhibition. The results directly demonstrate that down regulation of the IGF-IIR promo tes the growth of transformed D9 cells by sustaining IGF-II, which binds to and activates IGF-IR and insulin receptor to increase intracellular growth signals. (C) 2001 Academic Press.